secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2026-09-09T20:20:39+00:00
Accession:  0001213900-26-098405
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea shareholders approve reverse stock split up to 1:20; re-elect two directors
--------------------------------------------------------------------------------

- Annual meeting held Sept 9, 2026; quorum of 26,142,328 of 33,414,448 shares represented.
- Dr. Tiago Reis Marques re-elected with 18,381,039 votes for; Prof. Lawrence Steinman with 17,000,205.
- Ratified CBIZ as independent auditor for FY2026: 25,935,574 for, 199,988 against.
- Approved reverse stock split amendment (1:2 to 1:20) with 25,071,052 for, 1,053,169 against; board sets exact ratio.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390026098405/0001213900-26-098405-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390026098405/ea0304934-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-098405

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer